The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue
NCT05643599 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2025-01-27
Summary
For our working group, eighteen healthy Sprague-Dawley female rats were recruited and separated into three groups in an experimental animal laboratory.
Group 1 was given mad honey (n:6) (80 mg/kg); Group 2 was given normal honey (n:6) (80 mg/kg), and Group 3 was the control group (n:6). The groups were given normal and mad honey by oral gavage for 30 days in this study. Rats were anesthetized intramuscularly with 50 mg/kg ketamine and 5 mg/kg xylazine on the 30th day of the study. At the conclusion of the study, female rats in the proestrus phase of the estrous cycle (as indicated by vaginal smear) were sacrificed and their ovarian tissues were placed in neutral formalin solution.
Conditions
- Ovary Disease
Interventions
- DIETARY_SUPPLEMENT
-
Mad Honey
mad honey (80 mg/kg); (n:6)
- DIETARY_SUPPLEMENT
-
Normal Honey
normal honey (80 mg/kg),(n:6)
- DIETARY_SUPPLEMENT
-
Control
Control
Sponsors & Collaborators
-
Celal Bayar University
lead OTHER
Principal Investigators
-
Gulsen Gurgen · Manisa Celal Bayar University
-
Suha Turkmen · Karadeniz Teknik University
Eligibility
- Min Age
- 8 Weeks
- Max Age
- 10 Weeks
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2022-12-15
- Completion
- 2022-12-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
NCT06271928 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients
NCT01782911 ·Status: COMPLETED ·Phase: NA
-
Adolescent Polycystic Ovary Syndrome on a Low-carbohydrate Diet
NCT06429618 ·Status: COMPLETED
-
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
NCT03252223 ·Status: COMPLETED ·Phase: PHASE4
-
Absorption and Tolerability Studies of an Emulsion Containing the Coconut Oil-derived Glycerol Tridecanoate in Healthy Men
NCT03255889 ·Status: WITHDRAWN ·Phase: PHASE1
-
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247 ·Status: COMPLETED ·Phase: NA
-
Exogenous Ketone Ester in Women with Polycystic Ovary Syndrome.
NCT05762822 ·Status: COMPLETED ·Phase: NA
-
Effects of Isotretinoin on The Gonads and Hirsutism
NCT02855138 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894 ·Status: COMPLETED
-
Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers
NCT06339476 ·Status: COMPLETED ·Phase: NA
-
Ovarian Histopathology and Laparoscopic Assessment of Premature Ovarian Failure
NCT03412487 ·Status: UNKNOWN ·Phase: NA
-
Metabolism, Circadian Rhythms and Ovarian Function
NCT05007834 ·Status: RECRUITING
-
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
NCT06227676 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
NCT06426771 ·Status: COMPLETED
-
Caloric Intake and Ovarian Reserve
NCT03604770 ·Status: WITHDRAWN
-
Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary Syndrome
NCT06970821 ·Status: COMPLETED
-
Oxidative Stress in Polycystic Ovary Syndrome With Periodontal Disease and Dental Caries Lesions
NCT03594968 ·Status: COMPLETED
-
Effect of Visceral Manipulation on PCOS
NCT05029492 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Hyperandrogenism in Type 1 Diabetes
NCT04979377 ·Status: COMPLETED
-
MEnstrual Cycle pHase ANd dIabeteS Management
NCT07004504 ·Status: COMPLETED
-
Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary Patients
NCT05830487 ·Status: UNKNOWN ·Phase: NA
-
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
NCT01422096 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Subcutaneous Adipose Tissue in Cases With Polycystic Ovarian Syndrome
NCT01310569 ·Status: COMPLETED
-
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
NCT01422707 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
NCT03316469 ·Status: UNKNOWN ·Phase: NA